Tuesday - July 1, 2025
Association for Accessible Medicines Statement on Biden-Harris Administration's 100-Day Supply Chain Review
June 09, 2021
WASHINGTON, June 9 -- The Association for Accessible Medicines issued the following statement:

* * *

The Association for Accessible Medicines (AAM) supports the Biden-Harris administration's 100-day review of the pharmaceutical and active pharmaceutical ingredient (API) supply chains.

"The Biden-Harris administration has produced a thoughtful plan to strengthen the security of the U.S. pharmaceutical supply chain that recognizes the importance of . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products